Clinical trial results in 31 participants randomised to prednisone or placebo following gradual withdrawal of prednisone, according to baseline prednisone dose
Study group | Clinical trial results | Baseline prednisone dose | Total | |||
1 mg | 2 mg | 3 mg | 4 mg | |||
Prednisone | Number randomised | 1 | 2 | 10 | 2 | 15 |
Withdrew (lack of efficacy) | 0 | 0 | 3 | 0 | 3* | |
Completed trial | 1 | 2 | 6 | 1 | 10* | |
Withdrew (administrative) | 0 | 0 | 1 | 1 | 2 | |
Placebo | Number randomised | 0 | 1 | 12 | 3 | 16 |
Withdrew (lack of efficacy) | 0 | 1 | 9 | 1 | 11* | |
Completed trial | 0 | 0 | 2 | 2 | 4* | |
Withdrew (administrative) | 0 | 0 | 1 | 0 | 1 | |
Total | 1 | 3 | 22 | 5 | 31 |
*For 28 participants who either completed the trial or withdrew because of lack of efficacy, pā=ā0.021 by Fisher exact test (prednisone vs placebo). For all 31 randomised participants, pā=ā0.032 by Fisher exact test (prednisone vs placebo).